#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA626151	ADME	Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
2.	ALA626152	ADME	Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
3.	ALA626153	ADME	Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
4.	ALA876816	ADME	Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug	Rattus norvegicus	7	ALA1132212	organism-based format	Scientific Literature
5.	ALA626186	ADME	Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
6.	ALA877589	ADME	Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
7.	ALA625430	ADME	Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
8.	ALA631982	ADME	Bioavailability in rat after i.d. administration	Rattus norvegicus	7	ALA1132212	organism-based format	Scientific Literature
9.	ALA631983	ADME	Percent bioavailability (F%) was determined in dogs fed after oral administration of 25 mg/kg of the compound	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
10.	ALA631984	ADME	Percent bioavailability (F%) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
11.	ALA635561	ADME	Time of maximum plasma concentration (Tmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
12.	ALA635562	ADME	Time of maximum plasma concentration (Tmax) was determined in rats after intraduodenal administration of the drug.	Rattus norvegicus	7	ALA1132212	organism-based format	Scientific Literature
13.	ALA635563	ADME	Time of maximum plasma concentration (Tmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
14.	ALA633428	ADME	Plasma half life was determined in dogs after intravenous administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
15.	ALA633429	ADME	Plasma half life was determined in rats after intravenous administration of the drug.	Rattus norvegicus	7	ALA1132212	organism-based format	Scientific Literature
16.	ALA635608	ADME	Volume of distribution (Vdss) was determined in dogs after intravenous administration of 25 mg/kg of the compound.	Canis lupus familiaris	1	ALA1132212	organism-based format	Scientific Literature
17.	ALA655298	Functional	Antiviral activity was determined based on inhibition of HIV-1 IIIB induced cytopathic effects in CEM-SS cells in vitro using tetrazolium reagent.	Homo sapiens	11	ALA1132212	cell-based format	Scientific Literature
18.	ALA656644	Toxicity	Toxic concentration was determined for CEM-SS cells	Homo sapiens	11	ALA1132212	cell-based format	Scientific Literature
19.	ALA1050927	Binding	Inhibition of Plasmodium falciparum plasmepsin-2	Plasmodium falciparum	2	ALA1154121	single protein format	Scientific Literature
20.	ALA1050931	Binding	Inhibition of Plasmodium malariae plasmepsin-4	Plasmodium malariae	1	ALA1154121	assay format	Scientific Literature